Dipentum (MEDA Pharmaceuticals)


Welcome to the PulseAid listing for the Dipentum drug offered from MEDA Pharmaceuticals. This Aminosalicylate [EPC],Aminosalicylic Acids [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: MEDA Pharmaceuticals
NON-PROPRIETARY NAME: olsalazine sodium
SUBSTANCE NAME: OLSALAZINE SODIUM
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Aminosalicylate [EPC],Aminosalicylic Acids [Chemical/Ingredient]
ROUTE: ORAL
DOSAGE FORM: CAPSULE, GELATIN COATED
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2015-05-15
END MARKETING DATE: 0000-00-00


Dipentum HUMAN PRESCRIPTION DRUG Details:

Item DescriptionDipentum from MEDA Pharmaceuticals
LABELER NAME: MEDA Pharmaceuticals
DEA SCHEDULE:
ACTIVE STRENGTH: 250(mg/1)
START MARKETING DATE: 2015-05-15
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0037-6860_43f6c437-5c6a-4171-893a-c5669a8fa082
PRODUCT NDC: 0037-6860
APPLICATION NUMBER: NDA019715

Other OLSALAZINE SODIUM Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Alaven Pharmaceutical LLCDipentum
Carilion Materials ManagementDipentum
MEDA PharmaceuticalsDipentum